Baylor College of Medicine: Second-Generation COVID-19 Vaccine Clinical Trial Starts at BCM
May 27, 2021
May 27, 2021
HOUSTON, Texas, May 27 (TNSRes) -- The Baylor College of Medicine issued the following news:
Baylor College of Medicine investigators are recruiting volunteers for a multicenter Phase 1 clinical trial to examine the safety, tolerability and immune response for different doses of a two-part, investigational COVID-19 vaccine regimen.
"Gritstone Oncology's COVID-19 vaccine candidate has been designed to broaden the immune response to SARS-CoV-2, the virus that causes . . .
Baylor College of Medicine investigators are recruiting volunteers for a multicenter Phase 1 clinical trial to examine the safety, tolerability and immune response for different doses of a two-part, investigational COVID-19 vaccine regimen.
"Gritstone Oncology's COVID-19 vaccine candidate has been designed to broaden the immune response to SARS-CoV-2, the virus that causes . . .